1. |
Gan TJ, Joshi GP, Zhao SZ, et al. Presurgical intravenous parecoxib Sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects[J]. Acta Anaesthesiol Scand, 2004, 48(9): 1194-1207.
|
2. |
Peck TE, Williams M, Hammond E. Pharmacology for anaesthesia and intensive care[M]. London: Greenwich Medical Media Ltd, 2000: 120-122.
|
3. |
Barton SF, Langeland FF, Snabes MC, et al. Efficacy and safety of intravenous parecoxib Sodium in relieving acute postoperative pain following gynecologic laparotomy surgery[J]. Anesthesiology, 2002, 97(2): 306-314.
|
4. |
楊樹勤. 中國醫學百科全書·醫學統計學分冊[M]. 上海: 上海科學技術出版社, 1985: 205.
|
5. |
Willis WD. Role of neurotransmitters in sensitization of pain responsers[J]. Ann NY Acad Sci, 2001, 933(2): 142.
|
6. |
蔣宗明, 陳忠華, 陳念平, 等. 帕瑞昔布鈉超前鎮痛對骨科患者術后血P物質、TNF-α和IL-6水平影響[J]. 河北醫科大學學報, 2010, 31(4): 425-428.
|
7. |
Bajaj P, Ballary CC, Dongre NA, et al. Role of parecoxib in pre-emptive analgesia: comparison of the efficacy and safety of pre- and postoperative parecoxib in patients undergoing general surgery[J]. J Indian Med Assoc, 2004, 102(5): 272, 274, 276-278.
|
8. |
周橋靈, 張文璇, 楊承祥, 等. 帕瑞昔布鈉超前鎮痛對燒傷患者熱休克蛋白70和白細胞介素-6水平的影響[J]. 臨床麻醉學雜志, 2012, 28(1): 37-39.
|
9. |
Klaus H, Joke N, Hugo K VA, et al. Remifentanil directly activates human N-methyl-D-aspartate receptors expressed in xenopus laevis oocytes[J]. Anesthesiology, 2004, 100(6): 1531-1537.
|
10. |
Vincent J, Philippe R, Bruno G, et al. Remifentanil-induced post-operative hyperalgesia and its prevention with small-dose ketamine[J]. Anesthesiology, 2005, 103(1): 147-155.
|
11. |
蘇志源, 陳郡興, 譚正玲, 等. 帕瑞昔布鈉抑制瑞芬太尼術后痛覺過敏的量效關系[J]. 臨床醫學工程, 2011, 18(4): 528-529.
|
12. |
楊程, 楊海基, 徐曉紅, 等. 帕瑞昔布預防全麻術后躁動和咽喉痛的臨床研究[J]. 實用藥物與臨床, 2012, 13(2): 105-106.
|